Barely Significant
← all excerpts

Formulation of Modified-Release Bilayer Tablets of Atorvastatin and Ezetimibe: An <i>In-Vitro</i> and <i>In-Vivo</i> Analysis.

Polymers (Basel) · 2022 · PMC9506081 · PMID 36145914

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantp < 0.001actually significant
Negative Control Group The cholesterol level, HDL and VLDL showed a non-significant increase when compared with the negative control group, whereas there was a highly significant ( p < 0.001) increase in triglyceride levels ( Figure 6 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.